MedTrace Logo

Essential Fatty Acid (EFA) Nutrition 5-Year-Olds Follow-Up Study

NCT01112904 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 98

Last updated 2015-04-15

No results posted yet for this study

Summary

Docosahexanoic acid (DHA) is concentrated in the human brain. Before birth, DHA is transferred across the placenta, but transfer depends on maternal DHA intake. After birth, DHA is provided by breast milk or the child's diet. This study addresses whether DHA intakes are adequate to support human brain development.

In a previous study "N-3 Fatty Acid Requirements for Human Development" (C03-0242), pregnant women were randomly assigned to 400 mg/day DHA or placebo from 16 weeks of gestation until infant delivery. Blood DHA in gestation, and infant development to 18 months were assessed. This follow-up study will assess if maternal DHA in gestation has long-term influence on child development when assessed at 5 years and the impact of the child's own diet.

Conditions

  • Docosahexanoic Acid (DHA) Status

Sponsors & Collaborators

  • University of British Columbia

    lead OTHER

  • Canadian Institutes of Health Research (CIHR)

    collaborator OTHER_GOV

Principal Investigators

  • Sheila M. Innis, Dr. · University of British Columbia

  • Tim Oberlander, MD · University of British Columbia

Eligibility

Min Age
19 Years
Max Age
40 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2014-11-30
Completion
2014-11-30

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01112904 on ClinicalTrials.gov